Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2013
10/23/2013CN102813821B Preparation method for traditional Chinese medicine for treating stomach heat type insomnia
10/23/2013CN102805813B Method for preparing traditional Chinese medicine for treating chilli addiction type insomnia
10/23/2013CN102793865B Preparation method of traditional Chinese medicine for treating stomach disorder type insomnia
10/23/2013CN102757880B Maca health-care wine and preparation method thereof
10/23/2013CN102755490B Flavored nine-Xiang powder for treating Parkinson's disease
10/23/2013CN102614470B External Chinese herbal composition for treating sequela of apoplexy
10/23/2013CN102579998B Chinese medicine composition for curing insomnia
10/23/2013CN102579956B Medicament composition and application thereof
10/23/2013CN102579846B Chinese patent medicament wind-calming and pain-relieving granules for treating migraine and preparation method thereof
10/23/2013CN102451465B Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction
10/23/2013CN102362908B Medicinal composition for treating kidney-yang deficiency and preparation method thereof
10/23/2013CN102276594B Iloperidone medicinal cocrystal and preparation method thereof
10/23/2013CN102258738B Chinese medicinal prescription for treating craniocerebral injury
10/23/2013CN102241667B 1-[(4-hydroxypiperidine-4-yl) methyl] pyridine-2(1H)-one derivatives, preparation method and use thereof
10/23/2013CN102210800B Application of citron daylily and citron daylily general flavone
10/23/2013CN102127004B Azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them
10/23/2013CN102100777B Medicinal liquor for treating stroke sequela
10/23/2013CN101845057B Substituted phenol for methylal phosphate anesthetic and sedative drugs and preparation method thereof
10/23/2013CN101757058B General flavone extract of hollyhock flower, preparation thereof and application
10/23/2013CN101730530B Titration of tapentadol
10/23/2013CN101679298B Fused bicyclic heteroaryl derivatives
10/23/2013CN101657194B Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and process thereof
10/23/2013CN101106996B Use of oxycodone for treating visceral pain
10/22/2013US8563715 Pyrimidine derivative having cell protecting effect and uses thereof
10/22/2013US8563538 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/22/2013US8563525 Methods of treating an inflammatory-related disease
10/22/2013US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
10/22/2013US8563014 Modafinil oral lyophilizate
10/22/2013US8563007 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563000 Melanocortin receptor ligands modified with hydantoin
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013US8562951 Methods for classifying and treating physiologic brain imbalances using quantitative EEG
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2588295C Method and composition for administering an nmda receptor antagonist to a subject
10/22/2013CA2580981C Stabilized human igg4 antibodies
10/22/2013CA2538146C Pyridomorphinans, pyridazinomorphinans and use thereof
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/17/2013WO2013155054A1 Compositions and methods for treating cough
10/17/2013WO2013154744A1 Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
10/17/2013WO2013154712A1 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
10/17/2013WO2013154410A1 Use of phenobarbital (phb) in small doses in the treatment of autonomic dysregulations such as sympathetic hyperactivity
10/17/2013WO2013154409A1 Use of venlafaxine in the treatment of autonomic dysregulations with sympathetic deficit
10/17/2013WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013153535A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
10/17/2013WO2013152717A1 Fused pyrimidine compound, and preparation method, intermediate, composition， and uses thereof
10/17/2013WO2013152704A1 5-amino-1,4-dihydro-1,8-naphthyridine derivative and pharmaceutical composition and use thereof
10/17/2013WO2012136351A8 Tapentadol for treating pain associated with trigeminal neuralgia
10/17/2013US20130274521 Process for the preparation of and crystalline forms of optical enantiomers of modafinil
10/17/2013US20130274293 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/17/2013US20130273175 Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
10/17/2013US20130273162 Oral Film Containing Opiate Enteric-Release Beads
10/17/2013US20130273158 Extended release compositions of quetiapine
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273018 Recombinant human cln2 protein and methods of its production and use
10/16/2013EP2650367A1 Human monoclonal antibody
10/16/2013EP2650288A1 Sleep-improving agent
10/16/2013EP2650284A1 Heterocyclic derivatives as metabotropic glutamate receptor modulators
10/16/2013EP2650011A1 Method of treatment or prophylaxis
10/16/2013EP2650010A1 Method of treatment or prophylaxis
10/16/2013EP2650008A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2650007A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2649993A1 Stabilizer of acetaminophen
10/16/2013EP2649070A1 Triazolopyridine compounds
10/16/2013EP2649069A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
10/16/2013EP2649066A1 Hydantoin derivatives useful as kv3 inhibitors
10/16/2013EP2649064A1 Novel triazole compounds iii
10/16/2013EP2649048A1 Multifunctional nitroxide derivatives and uses thereof
10/16/2013EP2648732A1 Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
10/16/2013EP2648731A1 Carboxamide compounds and their use as calpain inhibitors v
10/16/2013EP2648724A1 Hydroxylated aminotriazole derivatives as alx receptor agonists
10/16/2013EP2648707A1 Hydroxylated tricyclic compounds
10/16/2013EP2648699A2 Dosage form
10/16/2013EP2648513A1 Methods and compositions useful for promoting sleep in animals
10/16/2013CN103351985A Low-degree health care liquor and preparation method thereof
10/16/2013CN103351437A Lingo binding molecules and pharmaceutical use thereof
10/16/2013CN103351415A Method for preparing salidrosides with a series of purities from glossy privet fruit
10/16/2013CN103351387A Preparation method of pyrroloquinolinequinone lithium salt crystal and applications thereof
10/16/2013CN103351377A Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
10/16/2013CN103351308A Positively charged water-soluble 4-acetamidophenol having rapid skin penetration speed, and related compound prodrug thereof
10/16/2013CN103351281A Marine-derived sesterterpene compounds, preparation method and application thereof
10/16/2013CN103349779A Healthcare soft capsule containing elements, vitamins and vegetable polyketide synthase and used for controlling cardiovascular and cerebrovascular diseases
10/16/2013CN103349776A Edaravone injection solution and preparation method thereof
10/16/2013CN103349756A Traditional Chinese medicine composition for treating depression
10/16/2013CN103349741A Compound essential oil for easing anxiety
10/16/2013CN103349737A Traditional Chinese medicine composite for treating headache and preparation method of traditional Chinese medicine composite
10/16/2013CN103349736A Traditional Chinese medicine composition used for treating nervous headache
10/16/2013CN103349732A Dendrobium officinale kimura et migo-panax quinquefolius buccal tablets for diabetes patients, and preparation method thereof
10/16/2013CN103349727A Xinnaoan
10/16/2013CN103349721A Medicine for treating hemiplegia and preparation method of medicine
10/16/2013CN103349708A Qi reinforcing and blood nourishing and liver and kidney tonifying drug and preparation method thereof
10/16/2013CN103349696A Compound essential oil for removing sense of fear
10/16/2013CN103349694A Medicine used for treating women postpartum diseases
10/16/2013CN103349692A Traditional Chinese medicine preparation for treating migraine and trigeminal neuralgia
10/16/2013CN103349683A Miao medicine for treating facial neuritis and preparation method thereof
10/16/2013CN103349682A Traditional Chinese medicine composition for treating cervical spondylosis
10/16/2013CN103349667A Use of icariin in prevention and treatment of traumatic brain injury
10/16/2013CN103349662A Application of Myriberine A in anti-depression drug preparation
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 1833